| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -8.4e-05 | 1 |